Both founders of Conflux are executive directors of Leading Medical Biotechnology.
Powered by ChatGPTPublic information shows that Conflux's two founders, Long Fan and Wu Ming, are both executive directors of Leading Pharmaceutical & Biotechnology, a Hong Kong-listed company. Currently, the total market cap of Leading Pharmaceutical & Biotechnology is HK$371 million, equivalent to approximately $47.26 million. The total market cap of the Conflux ($CFX) token is $393 million, currently ranked 138th in the Cryptocurrency market cap rankings. ChainCatcher previously reported that Hong Kong-listed company Leading Pharmaceutical & Biotechnology Co., Ltd. (00399) announced the signing of a memorandum of understanding to acquire all the equity of a target company, provided that the target company completes the acquisition of Conflux blockchain-related assets. The acquisition price will be paid in cash, company shares, or convertible bonds, with the specific amount to be determined. [ChainCatcher]